Log In
Print this Print this

bendamustine RTD (EP-3101)

  Manage Alerts
Collapse Summary General Information
Company Eagle Pharmaceuticals Inc.
DescriptionReady-to-dilute formulation of bendamustine, an alkylating agent, requiring 500 mL saline or a mixture of sodium chloride and dextrose
Molecular Target DNA
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today